These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12417426)

  • 1. UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
    Dennis JW; Pawling J; Cheung P; Partridge E; Demetriou M
    Biochim Biophys Acta; 2002 Dec; 1573(3):414-22. PubMed ID: 12417426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation.
    Demetriou M; Granovsky M; Quaggin S; Dennis JW
    Nature; 2001 Feb; 409(6821):733-9. PubMed ID: 11217864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells.
    Morgan R; Gao G; Pawling J; Dennis JW; Demetriou M; Li B
    J Immunol; 2004 Dec; 173(12):7200-8. PubMed ID: 15585841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the GlcNAc(beta)1,2Man(alpha)- moiety in mammalian development. Null mutations of the genes encoding UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2 cause embryonic lethality and congenital muscular dystrophy in mice and men, respectively.
    Schachter H
    Biochim Biophys Acta; 2002 Dec; 1573(3):292-300. PubMed ID: 12417411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.
    Lagana A; Goetz JG; Cheung P; Raz A; Dennis JW; Nabi IR
    Mol Cell Biol; 2006 Apr; 26(8):3181-93. PubMed ID: 16581792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching.
    Chen HL; Li CF; Grigorian A; Tian W; Demetriou M
    J Biol Chem; 2009 Nov; 284(47):32454-61. PubMed ID: 19706602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa.
    Wang Y; Schachter H; Marth JD
    Biochim Biophys Acta; 2002 Dec; 1573(3):301-11. PubMed ID: 12417412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein glycosylation and cancer progression.
    Dennis JW; Granovsky M; Warren CE
    Biochim Biophys Acta; 1999 Dec; 1473(1):21-34. PubMed ID: 10580127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex N-glycan and metabolic control in tumor cells.
    Mendelsohn R; Cheung P; Berger L; Partridge E; Lau K; Datti A; Pawling J; Dennis JW
    Cancer Res; 2007 Oct; 67(20):9771-80. PubMed ID: 17942907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
    de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
    Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Glycans in cancer progression.
    Lau KS; Dennis JW
    Glycobiology; 2008 Oct; 18(10):750-60. PubMed ID: 18701722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control of T cell immune response through glycans in inflammatory bowel disease.
    Dias AM; Correia A; Pereira MS; Almeida CR; Alves I; Pinto V; Catarino TA; Mendes N; Leander M; Oliva-Teles MT; Maia L; Delerue-Matos C; Taniguchi N; Lima M; Pedroto I; Marcos-Pinto R; Lago P; Reis CA; Vilanova M; Pinho SS
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4651-E4660. PubMed ID: 29720442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of immune responses by N-acetylglucosaminyltransferase V during allergic airway inflammation.
    Shibui A; Nambu A; Shimura E; Yamaguchi S; Shiraishi C; Sato Y; Okumura K; Sugano S; Hozumi N; Nakae S
    Allergol Int; 2011 Sep; 60(3):345-54. PubMed ID: 21502802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.
    Partridge EA; Le Roy C; Di Guglielmo GM; Pawling J; Cheung P; Granovsky M; Nabi IR; Wrana JL; Dennis JW
    Science; 2004 Oct; 306(5693):120-4. PubMed ID: 15459394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice.
    Soleimani L; Roder JC; Dennis JW; Lipina T
    Genes Brain Behav; 2008 Apr; 7(3):334-43. PubMed ID: 17883406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.
    Priglinger CS; Obermann J; Szober CM; Merl-Pham J; Ohmayer U; Behler J; Gruhn F; Kreutzer TC; Wertheimer C; Geerlof A; Priglinger SG; Hauck SM
    PLoS One; 2016; 11(1):e0146887. PubMed ID: 26760037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans.
    Cheung P; Pawling J; Partridge EA; Sukhu B; Grynpas M; Dennis JW
    Glycobiology; 2007 Aug; 17(8):828-37. PubMed ID: 17483135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma.
    Kato A; Yutani M; Terao M; Kimura A; Itoi S; Murota H; Miyoshi E; Katayama I
    Exp Dermatol; 2015 Aug; 24(8):585-90. PubMed ID: 25876794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.
    Abdel Rahman AM; Ryczko M; Nakano M; Pawling J; Rodrigues T; Johswich A; Taniguchi N; Dennis JW
    Glycobiology; 2015 Feb; 25(2):225-40. PubMed ID: 25395405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages.
    Li D; Li Y; Wu X; Li Q; Yu J; Gen J; Zhang XL
    J Immunol; 2008 Mar; 180(5):3158-65. PubMed ID: 18292539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.